Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Calliditas Therapeutics AB

Closing information (x1000 EUR)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 108,768 Less Arrow 72,147 Less Arrow 22,426
Financial expenses 10,305 Less Arrow 3,385 Less Arrow 905
Earnings before taxes -41,188 More Arrow -36,791 Less Arrow -50,198
EBITDA -32,125 Less Arrow -36,756 Less Arrow -51,282
Total assets 167,560 More Arrow 175,496 Less Arrow 142,752
Current assets 114,920 More Arrow 126,902 Less Arrow 99,030
Current liabilities 36,693 Less Arrow 29,225 Less Arrow 13,244
Equity capital 30,174 More Arrow 68,857 More Arrow 98,591
- share capital 215 Less Arrow 214 Less Arrow 205
Employees (average) 181 Less Arrow 86 Less Arrow 56

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 18.0% More Arrow 39.2% More Arrow 69.1%
Turnover per employee 601 More Arrow 839 Less Arrow 400
Profit as a percentage of turnover -37.9% Less Arrow -51.0% Less Arrow -223.8%
Return on assets (ROA) -18.4% Less Arrow -19.0% Less Arrow -34.5%
Current ratio 313.2% More Arrow 434.2% More Arrow 747.7%
Return on equity (ROE) -136.5% More Arrow -53.4% More Arrow -50.9%
Change turnover 36,410 More Arrow 51,538 Less Arrow 22,340
Change turnover % 50% More Arrow 250% More Arrow 26141%
Chg. No. of employees 95 Less Arrow 30 More Arrow 33
Chg. No. of employees % 110% Less Arrow 54% More Arrow 143%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.